Background {#Sec1}
==========

Obesity, particularly abdominal obesity, is an important risk factor for impaired glycemic control, cardiometabolic diseases and increased mortality \[[@CR1]--[@CR4]\]. The prevalence of obesity is increasing in Sweden as well as globally \[[@CR5], [@CR6]\]. In Sweden in 2009, when this study was conducted, the prevalence of general obesity (BMI ≥ 30 kg/m^2^) was 11% in men, and 10% in women \[[@CR7]\]. Traditionally in type 1 diabetes mellitus (T1DM), people were lean, the prevalence of the metabolic syndrome was low, and cardiovascular complications were rare \[[@CR8]\]. Since the introduction of intensified insulin therapy in order to optimize glycemic control and to reduce microvascular complications, the prevalence of obesity, other features of the metabolic syndrome and cardiovascular complications have increased dramatically \[[@CR8]--[@CR10]\]. Cardiovascular disease is now a leading cause of death for persons with T1DM \[[@CR8]\]. Particularly girls/women with T1DM are at risk for developing overweight and obesity \[[@CR10]\].

Obesity has been associated with emotional eating, the tendency to eat when experiencing negative emotions \[[@CR11], [@CR12]\]. Emotional eating can be both a conscious behaviour to ease emotional distress, as well as an automatic reaction to unrecognized negative feelings i.e. reflexive emotional eating \[[@CR13]\]. The latter has been associated with alexithymia \[[@CR13]\], which is defined by difficulty identifying feelings, difficulty describing feelings, externally oriented thinking and constricted imaginative processes \[[@CR14]\]. Persons with alexithymia have difficulties distinguishing bodily sensations due to emotional arousal from bodily sensations of somatic origin \[[@CR14]\]. Alexithymia has been linked to obesity \[[@CR15]--[@CR17]\], and to cardiovascular mortality in men \[[@CR18]\].

Persons with T1DM have an increased risk of depression \[[@CR19]\]. The impact of depression on weight is depending on depression type \[[@CR20], [@CR21]\]. Melancholic depression is characterized by weight loss, whereas atypical depression is characterized by weight gain \[[@CR20]--[@CR22]\]. Whether either of these two depression types is more common in persons with T1DM is not known. Depression in diabetes have been linked to life style factors such as less physical activity and unhealthy diet \[[@CR23]\]. We have previously shown that self-reported depression in this population was associated with impaired glycemic control \[[@CR3]\] and increased midnight cortisol secretion \[[@CR24]\]. Even if there is evidence for a positive association between obesity and anxiety disorders \[[@CR25], [@CR26]\], the strength of the association is depending on anxiety subtype \[[@CR26]\]. There are gender differences, women are more affected by depression and anxiety than men, which unfortunately often go unrecognized and untreated \[[@CR27]\].

Since persons with obesity often are stigmatized and face prejudice and discrimination \[[@CR28], [@CR29]\], this may negatively impact self-identity and self-perception \[[@CR29]\]. Obese persons have indeed described self-hate, shame, guilt, and disgust directed to themselves \[[@CR29]\].

Diabetes emotional distress is an emotional response to a demanding health-related condition in diabetes \[[@CR30]\]. Failure to achieve diabetes treatment goals, such as maintaining or achieving normal weight, might induce diabetes emotional distress \[[@CR30]\], which could potentially be expressed as self-blame or self-hate.

Our main hypotheses were that psychological factors are linked to obesity, and that increased knowledge of these links might be beneficial for the development of new strategies to target obesity in persons with T1DM. Our main aim was to explore associations between obesity and depression, anxiety, alexithymia and self-image in a sample of persons with T1DM controlling for potential confounders such as smoking and physical inactivity. Secondary aims were to explore associations between abdominal and general obesity and cardiovascular complications in T1DM.

Methods {#Sec2}
=======

Participants and procedures {#Sec3}
---------------------------

This report has a cross sectional design and is one of three baseline analyses \[[@CR3], [@CR24]\] for a randomized controlled trial ([ClinicalTrials.gov](http://clinicaltrials.gov): NCT01714986) where "Affect School with Script Analysis" was tried against "Basic Body Awareness Therapy" for persons with diabetes, inadequate glycemic control and psychological symptoms \[[@CR31], [@CR32]\]. The participants were outpatients, recruited from one secondary care hospital diabetes clinic with a catchment population of 125,000 in southern Sweden during, the period 03/25/2009 to 12/28/2009. The participants were recruited consecutively by specialist diabetes physicians or diabetes nurses at regular follow up visits. In this study 284 persons with T1DM were included, 66% of the eligible patients, see Fig. [1](#Fig1){ref-type="fig"}. Somatic exclusion criteria were cancer, hepatic failure, end-stage renal disease, stroke with cognitive deficiency, or visual impairment to such a degree that reading the questionnaires was impossible. Mental exclusion criteria were psychotic disorder, bipolar disorder, severe personality disorder, severe substance abuse, or mental retardation. Patients underwent assessments with self-report instruments at the regular follow up visits; anthropometrics and blood samples were collected. Data regarding patients' diagnoses, cardiovascular complications, life style factors, and medication were collected from computerized medical records.Fig. 1Description of criteria for inclusion in this study of obesity in persons with T1DM

Self-report instruments {#Sec4}
-----------------------

Self-reported depression and anxiety were assessed by the Hospital Anxiety and Depression Scale (HADS) \[[@CR33]\]. The depression (HADS-D) and anxiety (HADS-A) subscales, consists of 7 statements each, with 4 response alternatives from 0 to 3. The cut off level ≥ 8 points, recommended by the constructors, was used for both subscales to define self-reported depression and anxiety \[[@CR33]\]. To try the validity of HADS, clinical psychiatric diagnosis and antidepressants use were tried against self-reported depression and self-reported anxiety.

Alexithymia was assessed by the Toronto Alexithymia Scale-20 items (TAS-20) which consists of 20 statements rated from 1 to 5 \[[@CR11], [@CR16], [@CR17], [@CR34], [@CR35]\]. The cut off level ≥ 61 points for TAS-20 total scores, recommended by the constructors, was used to define alexithymia \[[@CR17], [@CR34], [@CR35]\]. TAS-20 is based on three subscales "difficulty identifying feelings" (DIF), "difficulty describing feelings" (DDF), and "externally oriented thinking" (EOT). No normal values are presented for the subscales by the constructors \[[@CR34], [@CR35]\]. All three subscales were dichotomized at the 90th percentile.

Self-image measures were assessed by the Structural Analysis of Social Behavior assessment tool (SASB) \[[@CR36], [@CR37]\]. The questionnaire comprises 36 self-referential statements with response options on a scale from 0 to 100 with 10-point increments. The results were summarized into eight subscales (clusters): 1) self-emancipation, 2) self-affirmation, 3) self-love, 4) self-protection, 5) self-control, 6) self-blame, 7) self-hate, and 8) self-neglect. No normal values are presented for the subscales by the constructors \[[@CR37]\]. Subscales 1, 6, 7 and 8 were dichotomized at the 90th percentile. Subscales 2, 3, 4 and 5 were dichotomized at the 10th percentile.

Anthropometrics {#Sec5}
---------------

Waist circumference (WC), weight and length were measured by a nurse according to standard procedures. Abdominal obesity was defined as WC ≥ 1.02 m for men and as WC ≥ 0.88 m for women \[[@CR1], [@CR2], [@CR4]\]. General obesity was defined as Body Mass Index (BMI) ≥ 30 kg/m^2^ for both genders \[[@CR2]\].

Blood analyses {#Sec6}
--------------

Venous HbA1c was analyzed with high pressure liquid chromatography, HPLC - variant II, Turbo analyzer (Bio -- Rad®, Hercules, CA, USA) \[[@CR38]\], at the department of Clinical Chemistry, Växjö Central Hospital. High HbA1c was defined as DCCT \>8.6% (IFCC \>70 mmol/mol) \[[@CR3]\].

Data collection from medical records {#Sec7}
------------------------------------

Data regarding life style variables were collected. Smokers were defined as having smoked any amount of tobacco during the last year. Physical inactivity was defined as moderate activities, such as 30 min of walking, less than once a week.

Clinical psychiatric diagnoses were established prior to recruitment, and were dichotomized as having or not having a psychiatric diagnosis. Use of antidepressants was dichotomized as using or not using any type of antidepressant.

Diabetes specific treatment was divided into three groups: Multiple daily insulin injections (MDII); continuous subcutaneous insulin infusion (CSII); and MDII combined with oral antidiabetic agents (OAA).

Cardiovascular complications were defined as ischemic heart disease, stroke or transient ischemic attack.

Statistical analysis {#Sec8}
--------------------

Analysis of data distribution using histograms revealed that the test results for the self-report instruments, age and diabetes duration were not normally distributed. Data were presented as median (quartile (q)~1~, q~3~; min-max), or as median (10th, 90th percentile; min-max) and analyses were performed with Mann-Whitney *U* test. Fisher's exact test (two-tailed) was used to analyze categorical data. A backward elimination multiple logistic regression analysis with cardiovascular complications as dependent variable showed that abdominal obesity had a higher association than general obesity. Thus, abdominal obesity was chosen in subsequent multiple regression modelling. Different explanatory logistic regression models were elaborated for the associations, and calibrated and validated for goodness of fit with the data variables. First crude odds ratios (CORs) were calculated. Then variables with *P* ≤ 0.10 were entered into multiple logistic regression models (Backward: Wald). The Hosmer and Lemeshow test for goodness-of-fit and Nagelkerke R^2^ were used to evaluate and calibrate the models. Confidence intervals (CIs) of 95% were used. *P* \< 0.05 was considered statistically significant. SPSS® version 18 (IBM, Chicago, Illinois, USA) was used for all statistical analyses.

Results {#Sec9}
=======

Baseline data and test results for all and gender specified {#Sec10}
-----------------------------------------------------------

In this study of obesity and psychological states and traits in TIDM (*n* = 284, age 18--59 years, men 56%), persons with abdominal obesity (*n* (%) = 49 (17)) were compared with persons without abdominal obesity (*n* (%) = 235 (83)). Baseline data are presented in Table [1](#Tab1){ref-type="table"}. The women had 3.6 times higher prevalence of abdominal obesity than the men (29% compared to 8%, *P* \< 0.001). None of the participants had been diagnosed with an eating disorder, according to their medical records.Table 1Baseline characteristics for the 284 patients with T1DM presented for all and gender specifiedAllMenWomen*P* ^*a*^*N*284159125Age (years)42 (32, 51; 18--59)43 (32, 52)41 (30, 50)0.12^b^Diabetes duration (years)20 (11, 30; 1--55)21 (11--32)19 (11, 29)0.26^b^Abdominal obesity^c^49 (17)13 (8)36 (29)\<0.001General obesity^d^34 (12)11 (7)23 (18)0.005High HbA1c^e^78 (28)39 (24)39 (31)0.23Smoking ^f^28 (10)18 (12)10 (8)0.42Physical inactivity^g^31 (11)18 (12)13 (11)0.85Cardiovascular complications10 (4)6 (4)4 (3)\>0.99Clinical psychiatric diagnoses38 (13)16 (10)22 (17)0.079Antidepressants23 (8)11 (7)12 (10)0.51MDII^h^ and OAA^i^17 (6)6 (4)11 (9)0.15CSII^j^26 (9)13 (8)13 (10)MDII^h^241 (85)140 (88)101 (81)Data are *n* (%) or median (q~1~, q~3~; min-max)^a^Fisher's exact test unless otherwise specified^b^Mann-Whitney U test^c^Abdominal obesity: WC men/women (meters): ≥ 1.02/≥ 0.88^d^General obesity: BMI ≥ 30 kg/m^2e^High HbA1c: \>8.6% (\>70 mmol/mol)Missing values men/women: ^f^ *n* = 6/6; ^g^ *n* = 6/6^h^Multiple daily insulin injections^i^Oral antidiabetic agents. ^j^ Continuous subcutaneous insulin infusion

The test results for the self-report instruments are presented in Table [2](#Tab2){ref-type="table"}. Women had higher prevalence of self-reported anxiety (*P* \< 0.001), high self- blame (*P* \< 0.001), high self-hate (*P* = 0.001), low self-affirmation (*P* = 0.001), low self-love (*P* = 0.020), and high DIF (*P =* 0.036). Men had higher prevalence of high EOT (*P* \< 0.035).Table 2Test results for HADS, TAS-20 and SASB, for the 284 patients with T1DM presented for all and gender specifiedScores ^a^Prevalence^b^AllAllMenWomen*P* ^*c*^*N*284284159125HADS HADS-D scores/Depression (≥ 8p)3 (1, 8; 0--20)29 (10)15 (9)14 (11)0.70 HADS-A scores/Anxiety (≥ 8p)5 (1, 11; 0--18)86 (34)39 (24)57 (46)\<0.001 TAS-20 TAS-20 scores/Alexithymia (≥ 61p)46 (32, 64; 20--81)42 (15)19 (12)23 (18)0.13 DIF scores/high DIF (≥ 23 p)13 (8, 23; 7--31)32 (11)12 (8)20 (16)0.036 DDF scores /high DDF (≥ 18 p)12 (6, 18; 5--32)30 (11)17 (11)13 (10)\>0.99 EOT scores /high EOT (≥ 27 p)21 (13, 27; 8--33)31 (11)23 (14)8 (6)0.035SASB^d^ Self-emancipation scores /high self-emancipation (≥ 66 p)^d^50 (34, 66; 8--94)27 (10)18 (12)9 (7)0.31 Self-affirmation scores /low self-affirmation (≤ 38 p)^d^70 (38, 88; 8--100)32 (12)9 (6)23 (19)0.001 Self-love scores /low self-love (≤ 40 p)^d^64 (40, 86; 14--100)31 (11)11 (7)20 (16)0.020 Self-protection scores /low self-protection (≤ 30 p)^d^52 (30, 75; 5--95)28 (10)19 (12)9 (7)0.23 Self-control scores /low self-control (≤ 28 p)^d^52 (28, 74; 0--98)33 (12)18 (12)15 (12)0.85 Self-blame scores /high self-blame (≥ 52 p)^d^18 (0, 52; 0--95)37 (13)9 (6)28 (23)\<0.001 Self-hate scores /high self-hate (≥ 50 p)^d^16 (0, 50; 0--92)30 (11)8 (5)22 (18)0.001 Self-neglect scores /high self-neglect (≥ 48 p)^d^22 (5, 48; 0--80)31 (11)18 (11)13 (10)0.85^a^Data are median (10th, 90th percentile; min-max)^b^ *N* (%)^c^Fisher's exact test. ^d^Missing values men/women: *n* = 3/4

Cardiovascular complications and obesity {#Sec11}
----------------------------------------

Cardiovascular complications were associated with abdominal obesity (adjusted odds ratio (AOR) (CI) 5.2 (1.5--18.8), *P* = 0.011), whereas general obesity was not (AOR (CI) 0.9 (0.2--5.7), *P* = 0.95).

Comparisons between persons with and without abdominal obesity {#Sec12}
--------------------------------------------------------------

The results of the comparisons are presented in Table [3](#Tab3){ref-type="table"}. The 49 obese persons compared to the 235 non-obese had higher prevalence of high DIF (*P* = 0.005), self-reported anxiety (*P* = 0.007), cardiovascular complications (*P* = 0.016), high self-hate (*P* = 0.021), use of antidepressants (*P* = 0.038), and alexithymia (*P* = 0.046). The 13 obese men had higher prevalence of high DIF (*P* = 0.009) than the 146 non-obese men. The 36 obese women had higher prevalence of cardiovascular complications (*P* = 0.006) and use of antidepressants (*P* = 0.038) than the 89 non-obese women.Table 3Comparisons between T1DM patients with and without abdominal obesity for all and gender specifiedAll patientsMenWomenObesity^a^Non-obesity*P* ^a^Obesity^a^Non-obesity*P* ^a^Obesity^a^Non-obesity*P* ^a^N49235131463689Age (years)45 (35, 53)42 (31, 51)0.11^b^50 (34, 58)43 (32, 51)0.072 ^b^45 (35--51)40 (30--48)0.18^b^Diabetes duration (years)22 (14, 28)20 (11, 31)0.64^b^21 (8, 31)20 (12, 32)0.92 ^b^23 (15--29)18 (10--29)0.27^b^Depression (≥ 8p)^c^6 (12)23 (10)0.612 (15)13 (9)0.354 (11)10 (11)\>0.99Anxiety (≥ 8p)^d^25 (51)71 (30)0.0073 (31)35 (24)0.7421 (58)36 (40)0.078Alexithymia (≥ 61p)^e^12 (24)30 (13)0.0463 (23)16 (11)0.199 (25)14 (16)0.31High DIF (≥23 p)^e^12 (24)20 (8)0.0054 (31)8 (6)0.0098 (22)12 (14)0.28High DDF (≥ 18 p)^e^4 (8)26 (11)0.801 (8)16 (11)\>0.993 (8)10 (11)0.72High EOT (≥ 27 p)^e^2 (4)29 (12)0.130 (0)23 (16)0.222 (6)6 (7)\>0.99High self-emancipation (≥ 66 p)^f^6 (12)21 (9)0.433 (23)15 (10)0.183 (9)6 (7)0.72Low self-affirmation (≤ 38 p)^f^9 (19)23 (10)0.131 (8)8 (6)0.558 (23)15 (17)0.61Low self-love (≤ 40 p)^f^8 (17)23 (10)0.212 (15)9 (6)0.236 (17)14 (16)\>0.99Low self-protection (≤ 30 p)^f^5 (10)23 (10)\>0.991 (8)18 (13)\>0.994 (11)5 (6)0.28Low self-control (≤ 28 p)^f^8 (17)25 (11)0.322 (15)16 (11)0.656 (17)9 (10)0.36High self-blame (≥ 52 p)^f^9 (19)28 (12)0.241 (8)8 (6)0.558 (23)20 (23)\>0.99High self-hate (≥ 50 p)^f^10 (21)20 (9)0.0211 (8)7 (5)0.519 (26)13 (15)0.20High self-neglect (≥ 48 p)^f^7 (14)24 (10)0.451 (8)17 (12)\>0.996 (17)7 (8)0.19Smoking^g^4 (9)24 (11)0.801 (8)17 (12)\>0.993 (9)7 (8)\>0.99Physical inactivity^h^9 (19)22 (10)0.0842 (15)16 (11)0.657 (20)6 (7)0.054Cardiovascular complications5 (10)5 (2)0.0161 (8)5 (3)0.414 (11)00.006Clinical psychiatric diagnoses11 (22)27 (11)0.0621 (8)15 (10)\>0.9910 (28)12 (14)0.071Antidepressants8 (16)15 (6)0.0381 (8)10 (7)\>0.997 (19)5 (6)0.038MDII and OAA13 (27)4 (2)\<0.0013 (23)3 (2)0.00910 (28)1 (1)\<0.001CSII1 (2)25 (10)013 (9)1 (3)12 (14)MDII35 (71)206 (88)10 (77)130 (89)25 (69)76 (85)Obesity defined as men/women: WC ≥ 1.02/≥ 0.88 m. Data are *n* (%) or median (q~1~, q~3~)^a^Fisher's exact test unless otherwise indicated^b^Mann-Whitney *U* test^c^HADS-D^d^HADS-A^e^TAS-20^f^SASBMissing values for obese/non-obese men: ^f^ *n* = 0/3^g^ *n* = 0/6^h^ *n* = 0/6. Missing values for obese/non-obese women. ^f^ *n* = 1/3; ^g^ *n* = 2/4; ^h^ *n* = 1/5

Associations between psychological states and traits, life style variables and abdominal obesity {#Sec13}
------------------------------------------------------------------------------------------------

In Table [4](#Tab4){ref-type="table"} variables associated with abdominal obesity are presented in two models for all patients. In model 1, abdominal obesity was associated with women (AOR 4.9), physical inactivity (AOR 3.1), alexithymia (AOR 2.6), and age (per year) (AOR 1.04). In model 2, abdominal obesity was associated with women (AOR 4.9), physical inactivity (AOR 3.5), high DIF (AOR 3.1), and age (per year) (AOR 1.04). Treatment with the combination of MDII and OAA was strongly associated with obesity (COR 19.1).Table 4Associations between abdominal obesity and psychological, somatic and life style variables in the T1DM patientsAbdominal obesity\
(*N* = 265)Model 1Model 2COR*P*AOR*P* ^a^AOR*P* ^a^Gender (women)4.5 (2.3--9.0)\<0.0015.0 (2.4--10.3)\<0.0014.9 (2.4--10.2)\<0.001Depression (≥ 8p)^b^1.3 (0.5--3.3)0.61\-\-\--Anxiety (≥ 8p)^c^2.4 (1.3--4.5)0.0061.5 (0.7--3.1)0.271.3 (0.6--2.8)0.51Alexithymia (≥ 61p)^d^2.2 (1.0--4.7)0.0392.6 (1.1--6.0)0.028\--High DIF (≥23 p)^d^3.5 (1.6--7.7)0.002\--3.1 (1.3--7.5)0.011High DDF (≥18 p)^d^0.7 (0.2--2.1)0.55\-\-\--High EOT (≥ 27 p)^d^0.3 (0.1--1.3)0.11\-\-\--High self-emancipation (≥66 p)^e^1.4 (0.5--3.7)0.48\-\-\--Low self-affirmation (≤38 p)^e^2.1 (0.9--4.8)0.0911.0 (0.3--3.0)0.950.9 (0.3--2.6)0.85Low self-love (≤40 p)^e^1.8 (0.7--4.3)0.19\-\-\--Low self-protection (≤30 p)^e^1.0 (0.4--2.9)0.94\-\-\--Low self-control (≤28 p)^e^1.6 (0.7--3.9)0.27\-\-\--High self-blame (≥52 p)^e^1.7 (0.7--3.8)0.23\-\-\--High self-hate (≥50 p)^e^2.8 (1.2--6.3)0.0171.1 (0.4--3.1)0.801.1 (0.4--3.5)0.85High self-neglect (≥48 p)^e^1.5 (0.6--3.6)0.41\-\-\--Smoking^f^0.8 (0.3--2.4)0.66\-\-\--Physical inactivity^g^2.1 (0.9--4.9)0.0833.1 (1.2--8.1)0.0233.5 (1.3--9.1)0.012Age (per year)1.02 (1.00--1.05)0.111.04 (1.00--1.07)0.0241.04 (1.00--1.07)0.024Diabetes duration1.00 (0.98--1.03)0.77\-\-\--Cardiovascular complications5.2 (1.5--18.9)0.011\-\-\--Clinical psychiatric diagnoses2.2 (1.0--4.9)0.0440.9 (0.2--3.6)0.860.9 (0.2--3.8)0.93Antidepressants2.9 (1.1--7.2)0.0251.6 (0.6--4.7)0.381.6 (0.6--4.7)0.38MDII and OAA19.1 (5.9--62.0)0.001\-\-\--CSII0.2 (0.03--1.8)0.16\-\-\--MDII1\-\-\--*N* = 284 unless otherwise specified^a^ Multiple logistic regression analysis (Backward: Wald)^b^HADS-D^c^HADS-A^d^TAS-20^e^SASBMissing values: ^e^ *n* = 7^f^ *n* = 12^g^ *n* = 12. Model 1/model 2: Hosmer and Lemeshow Test 0.685/0.735; Nagelkerke R Square 0.192/0.20

Variables associated with abdominal obesity are presented for each gender in Table [5](#Tab5){ref-type="table"}. In men, high DIF (AOR 7.7) was associated with abdominal obesity. In women, use of antidepressants (AOR 4.3) and physical inactivity (AOR 3.6) were associated with abdominal obesity.Table 5Associations between abdominal obesity and psychological and life style variables presented for each genderAbdominal obesity in men\
(*N* = 159)Abdominal obesity in women\
(*N* = 115)COR*P*AOR*P* ^a^COR*P*AOR*P* ^a^Depression (≥ 8p) ^b^1.9 (0.4--9.3)0.45\--0.99 (0.29--3.4)0.98\--Anxiety (≥ 8p) ^b^1.4 (0.4--4.9)0.51\--2.1 (0.9--4.5)0.0711.7 (0.8--4.0)0.20Alexithymia (≥ 61p) ^c^2.4 (0.6--9.8)0.21\--1.8 (0.7--4.6)0.23\--High DIF (≥23 p) ^c^7.7 (1.9--30.4)0.0047.7 (1.9--30.4)0.0041.8 (0.7--5.0)0.23\--High DDF (≥18 p) ^c^0.7 (0.1--5.6)0.72\--0.7 (0.2--2.8)0.63\--High EOT (≥ 27 p) ^c^0.00\>0.99\--0.8 (0.2--4.2)0.81\--High self-emancipation (≥66 p) ^d^2.6 (0.6--10.3)0.19\--1.2 (0.3--5.3)0.76\--Low self-affirmation (≤38 p) ^d^1.4 (0.2--12.2)0.76\--1.4 (0.5--3.7)0.49\--Low self-love (≤40 p) ^d^2.7 (0.5--14.1)0.24\--1.1 (0.4--3.0)0.91\--Low self-protection (≤30 p) ^d^0.6 (0.1--4,7)0.61\--2.1 (0.5--8.3)0.29\--Low self-control (≤28 p) ^d^1.4 (0.3--7.1)0.65\--1.8 (0.6--5.4)0.32\--High self-blame (≥52 p) ^d^1.4 (0.2--12.2)0.76\--1.0 (0.4--2.5)0.96\--High self-hate (≥50 p) ^d^1.7 (0.2--14.3)0.66\--1.9 (0.7--5.1)0.17\--High self-neglect (≥48 p) ^d^0.6 (0.1--5.2)0.67\--2.3 (0.7--7.5)0.15\--Smoking ^e^0.6 (0.1--4.9)0.64\--1.1 (0.3--4.4)0.92\--Physical inactivity ^f^1.4 (0.3--6.9)0.67\--3.2 (1.0--10.5)0.0493.6 (1.1--11.8)0.037Clinical psychiatric diagnoses0.7 (0.1--6.0)0.77\--2.5 (1.0--6.4)0.0621.5 (0.4--6-7)0.57Age (per year)1.05 (0.99--1.11)0.0911.04 (0.98--1.10)0.191.02 (0.99--1.06)0.191.02 (0.99--1.06)0.21Antidepressants1.1 (0.1--9.6)0.91\--4.1 (1.2--13.8)0.0254.3 (1.2--15.0)0.022*N* (men/women) = 159/125 unless otherwise specified^a^Multiple logistic regression analysis (Backward: Wald)^b^HADS-D^c^HADS-A^d^TAS-20^e^SASBMissing values for men: ^d^ *n* = 3^e^ *n* = 6^f^ *n* = 6. Missing values for women^d^ *n* = 4^e^ *n* = 6^f^ *n* = 6. Men/women: Hosmer and Lemeshow Test 0.226/0.910; Nagelkerke R Square 0.10/0.105

Variables associated with women, alexithymia, DIF and physical inactivity - interaction tests {#Sec14}
---------------------------------------------------------------------------------------------

Associations with women: abdominal obesity (AOR 4.2 (2.0--8.7), *P* \< 0.001), self-hate (AOR 3.1 (1.2--8.1), *P* = 0.022), age (per year) (AOR 0.98 (0.96--1.00), *P* = 0.046), and self-reported anxiety (AOR 1.8 (1.0--3.2), *P* \< 0.050); and the *p*-values were higher than 0.36 for alexithymia, physical inactivity, low self-affirmation, physical inactivity, clinical psychiatric diagnosis, and use of antidepressants.

Associations with alexithymia: self-reported anxiety (AOR 3.6 (1.7--7.4), *P =* 0.001) and abdominal obesity (AOR 2.2 (1.0--4.9), *P* = 0.055); and the *p*-values were higher than 0.10 for physical inactivity, gender, low self-affirmation, high self-hate, physical inactivity, clinical psychiatric diagnosis, use of antidepressants, and age.

Associations with high DIF: self-reported anxiety (AOR 9.1 (3.2--26.0), *P* \< 0.001), low self-affirmation (AOR 2.7 (1.0--7.0), *P* = 0.47) and abdominal obesity (AOR 2.5 (1.0--6.1), *P* = 0.055); the *p*-values were higher than 0.24 for physical inactivity, gender, high self-hate, physical inactivity, clinical psychiatric diagnosis, use of antidepressants, and age.

Associations with physical inactivity: abdominal obesity (AOR 2.6 (1.1--6.3), *P* = 0.034) and age (per year) (AOR 0.95 (0.92--0.99), *P* = 0.006); and the *p*-values were higher than 0.13 for alexithymia, gender, self-reported anxiety, low self-affirmation, high self-hate, clinical psychiatric diagnosis, and use of antidepressants. Significant associations with abdominal obesity, women, alexithymia and physical inactivity are presented in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Illustration of significant associations found in this study

Validation of HADS {#Sec15}
------------------

Clinical psychiatric diagnosis was associated with self-reported depression (COR 10.8 (4.6--25.2), *P* \< 0.001) and self-reported anxiety (COR 2.8 (1.4--5.6), *P* = 0.003). Antidepressants were associated with self-reported depression (COR 9.8 (3.8--25.3), *P* \< 0.001) and self-reported anxiety (COR 3.4 (1.4--8.2), *P* = 0.006).

Discussion {#Sec16}
==========

In this cross-sectional study of a population sample of 284 persons with T1DM, age 18--59 years, consecutively recruited from one hospital diabetes outpatient clinic, we found that female gender, physical inactivity and alexithymia were independently associated with abdominal obesity. The women had nearly 4 times higher prevalence of abdominal obesity than the men. High level of the alexithymia subfactor "difficulty identifying feelings" was responsible for the association between alexithymia and abdominal obesity. Gender analyses showed clear differences. In men, a high level of "difficulty identifying feelings" was strongly linked to abdominal obesity. In women, physical inactivity and the use of antidepressants were linked to abdominal obesity. The prevalence of general obesity in the women with T1DM was almost twice as high as in women in the Swedish population. Cardiovascular complications were strongly associated with abdominal obesity.

Strengths of our study are first that we systematically investigated the psychological states and traits in a well-defined population of persons with T1DM. Second, we explored interactions between the included variables. For example, at a first sight self-reported anxiety seemed to be associated with abdominal obesity which it was not in the further analyses. Instead self-reported anxiety was associated with both alexithymia and women which in turn were associated with abdominal obesity. Third, when the associations with abdominal obesity were tried the results were congruent. Clinical psychiatric diagnosis was not associated with abdominal obesity. Excess negative emotions, expressed as self-reported depression, anxiety, high levels of self-blame, self-hate, or self-neglect, were not linked to abdominal obesity; neither were low levels of positive emotions, expressed as low self-affirmation, low self-love or low self-protection. Fourth, we had access to both waist circumference measures and BMI, and we could choose in the analyses to use abdominal obesity, which showed the highest association with cardiovascular complications. Fifth, we validated the self-report instrument for depression and anxiety. We found strong associations with clinical psychiatric diagnosis and the use of antidepressants for both subscales of the self-report instrument.

The main limitation in our study was the small number of obese persons, particularly when the gender sub analyses were performed. There are several possible type two errors. The prevalence of alexithymia and high DIF were higher in both women and men with abdominal obesity compared to the non-obese. Also, the prevalence of physical inactivity was higher in both men and women with abdominal obesity compared to the non-obese. Second, there are difficulties connected to using the SASB and TAS-20 subscales as there are no normal values presented by the designers of these self-report instruments. We chose to compare the most extreme test results with the remaining, and all subscales were therefore dichotomized either at the 10th or 90th percentile. A third limitation is that we did not include any self-report instrument assessing diabetes related emotional distress.

This study is to our knowledge the first to demonstrate a link between alexithymia, mainly the subfactor "difficulty identifying feelings", and abdominal obesity in persons with T1DM. However, an increased prevalence of alexithymia in persons with obesity but without diabetes has been shown \[[@CR11], [@CR15], [@CR16]\]. Whether the direction of the association between abdominal obesity and alexithymia goes one-way or two-way cannot be concluded by this cross-sectional study. Alexithymia could lead to obesity, but if obesity is followed by a cognitive decline, the ability to process emotions could also decline. Persons with severe cognitive deficiencies were however excluded. The link between physical inactivity and obesity, which probably is two-ways, is in accordance with previous research in non-diabetic populations \[[@CR39], [@CR40]\]. The importance of obesity in T1DM in this study was demonstrated by the strong association between abdominal obesity and cardiovascular complications, as shown in previous research \[[@CR1], [@CR2], [@CR8]\]. We found a gender difference with a higher obesity prevalence in the women than in the men, which also has been shown previously \[[@CR10]\].

By this study, a new target in diabetes care emerges, "increased emotional awareness", which today is not considered in conventional diabetes management. Persons with alexithymia have difficulties distinguishing bodily sensations due to emotional arousal from bodily sensations of somatic origin \[[@CR14]\]. Difficulty identifying feelings might thus make it difficult to distinguish hunger from emotions involved in stress, anxiety or boredom, factors which serve as triggers for emotional eating \[[@CR12]\]. One issue connected to diabetes emotional distress is that the affected persons do not know whether their mood and feelings are related to their diabetes or not \[[@CR41]\]. This is probably particularly difficult for persons with alexithymia. The link between alexithymia and obesity might be one explanatory factor for the increased cardiovascular mortality found in men with alexithymia \[[@CR18]\].

Treatment with a combination of multiple daily insulin injections and oral antidiabetic agents was associated with abdominal obesity in this study. Oral antidiabetic agents should however not be regarded as a cause of obesity, as they were added to insulin with the aim of reducing obesity and insulin resistance.

The women seemed to have more psychological symptoms than men, with higher prevalence of anxiety, high self-hate and self-blame, and low self-affirmation and self-love which also is in accordance with previous research \[[@CR27]\]. However, these factors were not associated with abdominal obesity. The use of antidepressants was associated with abdominal obesity in women but not in men, though the frequency of antidepressant use did not differ between men and women. To adequately analyse why antidepressants were associated with obesity in women only, we would have needed to know whether women were prescribed different types of antidepressants than men, the prescribed daily dose, and the duration of medication.

There are several subjects for future research. The mechanism for the demonstrated higher obesity prevalence in women, compared both to the men with T1DM and to women in the general population, was not explained by this study and further research of this subject is necessary. Further, it would be of interest to explore whether alexithymia and diabetes emotional distress is associated, which to our knowledge has not been studied. Finally, we propose that interventions focusing on increased emotional awareness should be performed and evaluated for persons with T1DM, obesity and alexithymia \[[@CR31], [@CR32], [@CR42]--[@CR44]\].

Conclusions {#Sec17}
===========

Abdominal obesity in T1DM was associated with women, alexithymia, particularly the alexithymia subfactor "difficulty identifying feelings", and physical inactivity. As abdominal obesity is detrimental in diabetes due to its association with cardiovascular complications, our results suggest two risk factor treatment targets: increased emotional awareness and increased physical activity.

AOR

:   Adjusted odds ratio

BMI

:   Body mass index

CI

:   Confidence interval

COR

:   Crude odds ratio

CSII

:   Continuous subcutaneous insulin infusion

DDF

:   Difficulty describing feelings

DIF

:   Difficulty identifying feelings

EOT

:   Externally oriented thinking

HADS-A

:   Hospital Anxiety and Depression scale-anxiety-anxiety subscale

HADS-D

:   Hospital Anxiety and Depression Scale-depression subscale

MDII

:   Multiple daily insulin injections

OAA

:   Oral antidiabetic agents

SASB

:   Structural Analysis of Social Behavior assessment tool

T1DM

:   Type 1 diabetes mellitus

TAS-20

:   Toronto Alexithymia Scale-20 items

WC

:   Waist circumference
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